Long term treatment of postmenopausal osteoporosis with calcitonin, alendronate, or alphacalcidiol

被引:0
作者
Demirel, GG [1 ]
Paker, N [1 ]
Yilmaz, H [1 ]
机构
[1] Istanbul Phys Med & Rehabil Ctr, Istanbul, Turkey
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
466
引用
收藏
页码:S181 / S181
页数:1
相关论文
共 50 条
[31]   Long-Term Treatment of Postmenopausal Osteoporosis [J].
Brown, Jacques P. .
ENDOCRINOLOGY AND METABOLISM, 2021, 36 (03) :544-552
[32]   CALCITONIN FOR PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS [J].
BODY, JJ .
CLINICAL RHEUMATOLOGY, 1995, 14 :18-21
[33]   POSTMENOPAUSAL OSTEOPOROSIS - PREVENTION AND TREATMENT WITH CALCITONIN [J].
PRELEVIC, GM ;
ADASHI, EY .
GYNECOLOGICAL ENDOCRINOLOGY, 1992, 6 (02) :141-147
[34]   Cyclical alendronate treatment in postmenopausal women with osteoporosis [J].
Kösüs, A ;
Çapar, M ;
Kösüs, N .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2005, 91 (02) :182-184
[35]   Treatment with etidronate or alendronate in postmenopausal osteoporosis. [J].
Lissens, MA .
JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 :S277-S277
[36]   Long-term effects of treatment with alendronate for patients with osteoporosis [J].
Nancy E Lane .
Nature Clinical Practice Rheumatology, 2007, 3 :426-427
[37]   Long-term effects of treatment with alendronate for patients with osteoporosis [J].
Lane, Nancy E. .
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (08) :426-427
[38]   Postmenopausal osteoporosis and alendronate [J].
Pérez-López, FR .
MATURITAS, 2004, 48 (03) :179-192
[39]   Alendronate in postmenopausal osteoporosis [J].
Liedholm, H ;
Linne, AB .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :733-734
[40]   Long-term treatment strategies for postmenopausal osteoporosis [J].
Cosman, Felicia .
CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (04) :420-426